Riedl, J.M.; Barth, D.A.; Brueckl, W.M.; Zeitler, G.; Foris, V.; Mollnar, S.; Stotz, M.; Rossmann, C.H.; Terbuch, A.; Balic, M.;
et al. C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study. Cancers 2020, 12, 2319.
https://doi.org/10.3390/cancers12082319
AMA Style
Riedl JM, Barth DA, Brueckl WM, Zeitler G, Foris V, Mollnar S, Stotz M, Rossmann CH, Terbuch A, Balic M,
et al. C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study. Cancers. 2020; 12(8):2319.
https://doi.org/10.3390/cancers12082319
Chicago/Turabian Style
Riedl, Jakob M., Dominik A. Barth, Wolfgang M. Brueckl, Gloria Zeitler, Vasile Foris, Stefanie Mollnar, Michael Stotz, Christopher H. Rossmann, Angelika Terbuch, Marija Balic,
and et al. 2020. "C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study" Cancers 12, no. 8: 2319.
https://doi.org/10.3390/cancers12082319
APA Style
Riedl, J. M., Barth, D. A., Brueckl, W. M., Zeitler, G., Foris, V., Mollnar, S., Stotz, M., Rossmann, C. H., Terbuch, A., Balic, M., Niedrist, T., Bertsch, T., Stoeger, H., Pichler, M., Olschewski, H., Absenger, G., Ficker, J. H., Gerger, A., & Posch, F.
(2020). C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study. Cancers, 12(8), 2319.
https://doi.org/10.3390/cancers12082319
